Trial Profile
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes : A Randomized Double-blind Placebo-controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIAMOND GLP1
- 07 Jul 2021 Status changed from recruiting to completed.
- 31 Oct 2019 Planned End Date changed from 1 Sep 2020 to 1 Mar 2021.
- 21 Feb 2019 Planned End Date changed from 1 Jun 2020 to 1 Sep 2020.